DanZhaoMDPhD

Gastrointestinal Cancer

Assistant professor, MD Anderson Cancer Center

Dr. Zhao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Dan Zhao is an oncologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. She received her education from Tongji Medical College and Peking Union Medical College has been in practice 12 years. She also speaks multiple languages, including Chinese (Mandarin). She specializes in gastrointestinal cancer and is experienced in gastrointestinal cancer including pancreatic cancer, immunotherapy, targeted therapy, and clinical cancer research.

City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2014 - 2017
Massachusetts General HospitalOncology, Translational cancer research, 2012 - 2014
National Cancer InstitutePost-Doctoral Fellowship, 2009 - 2012
Peking Union Medical CollegeClass of 2009, PhD, Oncology
Tongji Medical CollegeMD, 1999 - 2004

First Prize of Natural Science Award Ministry of Education, China, 2012
Third Prize of Medical Science and Technology Award Chinese Medical Association, 2012
Second Prize of Science and Technology Award Beijing City, China, 2012
Best Doctoral Thesis Award Beijing City, China, 2010
Leadership Award Tongji Medical College, 2003
Join now to see all

PubMed

Journal Articles

Updates on Immunotherapy for the Treatment of Skin Cancer.
Kang A, Zhao D, Yeh JJ, Lee DJ., Current Dermatology Reports., 2018

Books/Book Chapters

Pulmonary Adenocarcinoma: Approaches to Treatment
Chapter: Targeted Therapy in Non-Small Cell Lung Cancer (Beyond Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase)
Dickinson E, Zhao D, Reckamp K.Elsevier, 2019.
Oncology in the Precision Medicine Era: Value-Based Medicine
Chapter: Treatment Strategies in Head and Neck Cancers
Dan Zhao, Rebecca Pharaon, Erminia MassarelliEditors: Ravi Salgia.Springer Nature 2019

Abstracts/Posters

JNJ-61186372, a Human Bispecific EGFR and cMet Antibody, in Primary MET Exon14 Skipping Non-Small Cell Lung Cancer
Dan Zhao MD, PhD, Meena Thayu MD, Martin Shreeve MD, PhD, Roland Knoblauch MD, PhD, Joshua Curtin PhD, Amy Roshak BS, Matthew Lorenzi Ph, Ravi Salgia, MD, PhD, Marian..., IASLC Targeted Therapies of Lung Cancer Meeting 2020, Santa Monica, CA
Evaluation of immune-related adverse events in patients treated with sequential immunotherapy and tyrosine kinase inhibitor treatment in non-small cell lung cancer
Angel Ray Baroz, Isa Mambetsariev, Jeremy Fricke, Rebecca Pharaon, Dan Zhao, Marianna Koczywas, Erminia Massarelli, Ravi Salgia, Journal of Clinical Oncology 2020 38:15_suppl, e21562-e21562, ASCO 2020
Molecular and clinical features of hospital admissions and immunotherapy related adverse events of immune checkpoint inhibitors in thoracic malignancies
Dan Zhao MD, PhD, Haiqing Li PhD, Isa Mambestariev BA, Chen Chen MS, Jeremy Fricke BS, Prakash Kulkarni PhD, Yan Xing MD PhD, Erminia Massarelli MD PhD, Marianna Koczy..., ASCO annual meeting 2019, Chichago, IL
Alterations in STK11 to limit response to immune checkpoint inhibitors in lung cancer
Jeremy Fricke, Isa Mambetsariev, Rebecca Pharaon, Angel Ray Baroz, Dan Zhao, Erminia Massarelli, Marianna Koczywas, Ravi Salgia, Journal of Clinical Oncology 2020 38:15_suppl, e21503-e21503, ASCO 2020, 2020
Join now to see all

Experimental Drugs That Change Energy Supply in Cells Could Slow Brain Tumor GrowthMay 27th, 2020
Genetic Mutations in Pancreatic Cancer Are Paving the Way for a Potential VaccineFebruary 15th, 2024